Cargando…
Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases
Inflammatory eye diseases remain the most common clinical problem in ophthalmology. The secondary processes associated with inflammation, such as overproduction of reactive oxygen species (ROS) and exhaustion of the endogenous antioxidant system, frequently lead to tissue degeneration, vision blurri...
Autores principales: | Vaneev, Alexander N., Kost, Olga A., Eremeev, Nikolay L., Beznos, Olga V., Alova, Anna V., Gorelkin, Peter V., Erofeev, Alexander S., Chesnokova, Natalia B., Kabanov, Alexander V., Klyachko, Natalia L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067682/ https://www.ncbi.nlm.nih.gov/pubmed/33917028 http://dx.doi.org/10.3390/biomedicines9040396 |
Ejemplares similares
-
Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation
por: Kost, Olga A., et al.
Publicado: (2016) -
Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye
por: Vaneev, Alexander, et al.
Publicado: (2021) -
Nano- and Microsensors for In Vivo Real-Time Electrochemical Analysis: Present and Future Perspectives
por: Vaneev, Alexander N., et al.
Publicado: (2022) -
Chitosan-Covered Calcium Phosphate Particles Co-Loaded with Superoxide Dismutase 1 and ACE Inhibitor: Development, Characterization and Effect on Intraocular Pressure
por: Popova, Ekaterina, et al.
Publicado: (2023) -
Recent Advances in Nanopore Technology for Copper Detection and Their Potential Applications
por: Vaneev, Alexander N., et al.
Publicado: (2023)